Financial statements Pharma-Flos
Balance sheet data of PHARMA-FLOS
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 690,00 | 568,00 | 538,00 | 620,00 | 568,00 |
| A. Fixed assets | 17,00 | 14,00 | 27,00 | 25,00 | 23,00 |
| B. Current assets | 673,00 | 554,00 | 511,00 | 595,00 | 545,00 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - | - |
| Total liabilities | 690,00 | 568,00 | 538,00 | 620,00 | 568,00 |
| A. Equity | -216,00 | -306,00 | -218,00 | -86,00 | -68,00 |
| B. Liabilities and provisions for liabilities | 906,00 | 874,00 | 756,00 | 706,00 | 636,00 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.